http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100651338-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-002 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00 |
| filingDate | 2003-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2006-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100651338-B1 |
| titleOfInvention | Method for preparing optically active (R) -2-chloromandelic acid and its ester derivatives using yeast |
| abstract | The present invention relates to a method for preparing optically active (R) -2-chloromandelic acid ((R) -2-chloromandelic acid) and ester derivatives thereof using yeast (Baker's Yeast), and more specifically, to a phosphate buffer. Optical activity (R) -2-chloromandelic acid by biological method for selectively reducing alkyl 2-Chloro-benzoylformate in the presence of a solution using Baker's yeast and its It relates to a method for producing an ester derivative. The production method of the present invention uses yeast, which is inexpensive and easy to obtain, which makes the manufacturing process simple and economical, and has high optical purity and yield. n n n 2-chloromandelic acid, yeast, reduction reaction, clopidogrel, flavix, thrombolytic |
| priorityDate | 2003-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466480201 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466476470 |
Total number of triples: 13.